|
⚲
|
| Keyboard |
| Scheinberg David A
✚
|
|
|---|---|
| CIK # | 0001250316 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001250316] | |
| 4 | [0001250316] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SELLAS Life Sciences Group Inc | |
| Scheinberg David A | |
| Progenics Pharmaceuticals Inc | |
| Contrafect Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2026-01-07 | Grant | 50,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2025-01-10 | Grant | 18,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2025-01-10 | Grant | 12,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2024-01-22 | Grant | 6,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2024-01-22 | Grant | 10,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2023-02-02 | Grant | 9,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2023-02-02 | Grant | 2,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2022-01-31 | Grant | 7,125 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2022-01-31 | Grant | 1,900 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2021-03-04 | Grant | 7,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2020-03-12 | Grant | 6,500 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2019-07-11 | Grant | 25,000 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2019-07-01 | Option exercise | 10,000 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock
|
2019-07-01 | Option exercise | 10,000 | $5.33 | 53,300 |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2019-03-14 | Grant | 25,000 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2018-06-13 | Grant | 25,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2018-06-12 | Grant | 5,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2018-03-13 | Grant | 11,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 9,107 | ||
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2017-06-14 | Grant | 20,000 | $0.00 | |
| showing 20 of 32 most recent transactions | |||||